Upfront versus resection after neoadjuvant chemotherapy for pancreatic adenocarcinomas with venous contact: comparative analysis of operative and survival outcomes.
Fiche publication
Date publication
février 2022
Journal
Surgery
Auteurs
Membres identifiés du Cancéropôle Est :
Dr AVEROUS Gerlinde, Pr BACHELLIER Philippe
Tous les auteurs :
Addeo P, Cususmano C, Dufour P, Avérous G, Bachellier P
Lien Pubmed
Résumé
Neoadjuvant treatment before resection for pancreatic adenocarcinoma having contact with the splenomesentericoportal venous axis could improve the results of extended pancreatectomies. We compared the outcomes of upfront (UR) and resection after neoadjuvant chemotherapy (NAC) for pancreatic adenocarcinoma.
Référence
Surgery. 2022 Feb 26;: